Morrow, M <br/><br/>
TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL.  [electronic resource] 

 -  Oncogene  Jun 2007 
 - 4404-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1210227  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>B-Lymphocytes--physiology<br/>Binding Sites<br/>Core Binding Factor Alpha 2 Subunit--chemistry<br/>DNA--metabolism<br/>Dimerization<br/>Helix-Loop-Helix Motifs<br/>Hematopoietic Stem Cells--physiology<br/>Mice<br/>Mice, Inbred C57BL<br/>Oncogene Proteins, Fusion--chemistry<br/>Preleukemia--etiology<br/>Proto-Oncogene Proteins c-ets--chemistry<br/>Repressor Proteins--chemistry<br/>Retroviridae--genetics<br/>Transcription, Genetic<br/>Translocation, Genetic<br/>ETS Translocation Variant 6 Protein